Amanta Healthcare Board of Directors

Get the latest insights into the leadership at Amanta Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Bhavesh Patel Chairman & Managing Director
Mr. Nimesh Patel Non Executive Director
Mr. Kshitij Patel Independent Director
Mr. Anjali Choksi Independent Director
Mr. Nitin Jain Independent Director
Mr. Pratik Gandhi Non Executive Director

Amanta Healthcare Share price

AMANTA

141.75

0 (0.00%)
NSE
BSE
Last updated on 9 Sep, 2025 | 15:51 IST
BUYSELL
Today's High

141.75

Today's Low

132.00

52 Week Low

0.00

52 Week High

141.75

The current prices are delayed, login to your account for live prices

Amanta Healthcare FAQs

The board at Amanta Healthcare consists of experienced professionals, including Mr. Bhavesh Patel , Mr. Nimesh Patel , and others, overseeing the company’s strategic and corporate governance.

Directors at Amanta Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Bhavesh Patel is the current chairman at Amanta Healthcare.

Executive directors at Amanta Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Amanta Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Amanta Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.